News
A new scientific publication involving Exacte Labs
2022
.jpg)
We invite you to read the scientific article about the Phase I clinical trial of Angipur, co-authored by Vasiliy Kazey, CEO of Exacte Labs. The scientific publication was published in the journal «Cardiovascular Therapy and Prevention».
Results of a clinical study on safety, pharmacokinetics and pharmacodynamics of an original antiplatelet preparation from the group of glycoproteins IIb/IIIa-receptor inhibitors in healthy volunteers
Fitilyov S.B., Glukhov Yu.F., Lukyanov S.V., Vozzhaev A.V., Shkrebneva I.I., Kazey V.I., Bondareva I.B.
The full text of the publication can be found here.
Other news
Presentation by Dmitry Grebenkin at the conference "Dialogues on Clinical Trials"
Exacte Labs - participant of the conference "Cosmetics Industry: Looking into the Future"
An employee of Exacte Labs took part in the roundtable discussion
Exacte Labs employees at the conference "Topical issues of prevention, diagnosis and treatment of tuberculosis in children and adolescents"